GENB
Generate Biomedicines, Inc.Company Information
- Company Name
- Generate Biomedicines, Inc.
- CIK
- CIK0002100782
- Category
- <br>Emerging growth company
- Ticker: Exchange
- GENB: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- GENB
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-04
- Last sale
- 2026-09-01
- Shares purchased (TTM)
- 9,398,800
- Shares sold (TTM)
- 1,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 98,106,246
- Shares outstanding
- 128,240,371
- Ownership
- 76.50%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 10.37%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 135 | 161 | ||||||
| Marketable Securities Current | 322 | 356 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 13 | 19 | ||||||
| Assets Current | 470 | 535 | ||||||
| Property Plant And Equipment Net | 27 | 28 | ||||||
| Operating Lease Right Of Use Asset | 55 | 58 | ||||||
| Other Assets Noncurrent | 9 | 5 | ||||||
| Assets | 562 | 626 | ||||||
Liabilities Current | ||||||||
| Accounts Payable Current | 6 | 8 | ||||||
| Deferred Revenue Current | 12 | 17 | ||||||
| Finance Lease Liability Current | 4 | 4 | ||||||
| Operating Lease Liability Current | 10 | 10 | ||||||
| Liabilities Current | 57 | 58 | ||||||
Liabilities Noncurrent | ||||||||
| Finance Lease Liability Noncurrent | 1 | 2 | ||||||
| Deferred Revenue Noncurrent | 0 | 1 | ||||||
| Operating Lease Liability Noncurrent | 48 | 49 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | ||||||
| Liabilities | 106 | 111 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 0 | 0 | ||||||
| Minority Interest | 0 | 0 | ||||||
Stockholders Equity | ||||||||
| Common Stock Value | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,261 | 1,252 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -805 | -738 | ||||||
| Stockholders Equity | 456 | 515 | ||||||
| Liabilities And Stockholders Equity | 562 | 626 | ||||||
| Related Party | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | ||||||
| Common Stock Shares Issued | 128 | 128 | ||||||
| Shares Outstanding | 128 | 128 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGenerate Biomedicines, Inc. (GENB) — SEC Financial Statements & Analysis
Generate Biomedicines, Inc. (GENB) is a pharmaceutical preparations company, incorporated in DE. Generate Biomedicines, Inc. trades on Nasdaq as: GENB. Generate Biomedicines, Inc. (GENB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Generate Biomedicines, Inc. carries a market cap of $2.16B, a P/B ratio of 4.74x, and an enterprise value of $2.03B. On the balance sheet, it maintains a current ratio of 8.30x, a quick ratio of 8.08x, working capital of $413.62M, a debt-to-equity ratio of 0.23x, a debt ratio of 0.19, and net debt of $-130.25M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.16B
- P/B TTM
- 4.74x
- Debt To Equity
- 0.23x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Generate Biomedicines, Inc. in?
Generate Biomedicines, Inc. (GENB) operates in the Pharmaceutical Preparations industry.
What exchange does GENB trade on?
Generate Biomedicines, Inc. (GENB) trades on the Nasdaq.
Where is Generate Biomedicines, Inc. incorporated?
Generate Biomedicines, Inc. is incorporated in DE.
When was Generate Biomedicines, Inc. (GENB)'s most recent SEC filing?
Generate Biomedicines, Inc. (GENB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is GENB's market cap?
Generate Biomedicines, Inc. (GENB) has a market capitalization of $2.16B as of 2026-06-30.